Literature DB >> 20930355

Transforming growth factor-β-1 polymorphisms are infrequent but exist at selected loci in oral submucous fibrosis.

R Rajendran1, R K Harish, Sukumaran Anil, Ravi Vidyadharan, Moinak Banerjee.   

Abstract

BACKGROUND: Oral submucous fibrosis (OSF) may be considered a collagen metabolic disorder resulting from areca-nut alkaloid exposure and individual variation in collagen metabolism. Due to the complexity of OSF pathogenesis, it is important to elucidate independent and interactive effects of polymorphisms of collagen-related genes on OSF risk.
MATERIALS AND METHODS: This study is focused on seven polymorphisms (SNPs) of transforming growth factor-beta-1 (TGF-beta-1) gene in patients with oral submucous fibrosis (OSF), belonging to south Indian ethnic extraction. The mean age at presentation was 43.9 years, range 23-72 years (n=50, M:F ratio, 2.6:1). DNA samples from 50 subjects of the same ethnic group and comparable demographic features who have had practiced the habit of areca-chewing of almost equal duration, but remained free of disease constituted the controls. All DNA samples were collected progressively and purified from peripheral blood employing standard protocols and tested for SNPs. They included two polymorphisms in the promoter region (C-509T and G-800A), three polymorphisms in exon-1 (Arg25Pro(G915C), Leu10Pro(T869C), Glu47Gly(A979G) and two in 5 ¢UTR regions (C→T(rs13306708) and G→A (rs9282871). The extracted DNA samples along with the primers underwent PCR amplification and the genotypic and allelic frequencies were calculated. All calculations were performed using the SPSS software. The PCR products were purified and subsequently sequenced using Flour S™ multi-imager system (Biorad). The sequenced data were analyzed using the BioEdit sequence analysis software.
RESULTS: Out of the seven polymorphisms analyzed, six such as two in the promoter region, three in exon-1 and one in 5¢UTR were found to have a " P" value above 0.05 and hence were not significant. The C→T transition (rs13306708) in the 5¢UTR region recorded a " P" value of 0.03 on comparison and hence was found to be significant. The allelic frequencies for this C→T transition in patients were 68.7% C and 31.2% T (27CC, 15CT, 8TT) and that in controls were 89.5% C and 10.4% T (42CC, 6CT, 2TT).
CONCLUSIONS: The polymorphism in 5¢UTR C-T in TGF beta 1 gene has a significant association with OSF, being a prime determinant in the pro-angiogenic pathway which has got direct bearing with the pathophysiology of the disease. The proximity of this polymorphism to the transcription site and the associated risk involved is discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20930355     DOI: 10.4103/0970-9290.70815

Source DB:  PubMed          Journal:  Indian J Dent Res        ISSN: 0970-9290


  5 in total

Review 1.  Cystatin C: Its role in pathogenesis of OSMF.

Authors:  P C Anila Namboodiripad
Journal:  J Oral Biol Craniofac Res       Date:  2014-03-17

2.  α4β1 integrin-dependent cell sorting dictates T-cell recruitment in oral submucous fibrosis.

Authors:  R Rajendran; K Deepthi; Nasser Nooh; Sukumaran Anil
Journal:  J Oral Maxillofac Pathol       Date:  2011-09

Review 3.  Leaving no stone unturned: Role of profibrotic genes in oral submucous fibrosis - A systematic review.

Authors:  Amritha James; Lekshmy Jayan; Ramya Ramadoss; Preethi Arunachalam
Journal:  J Oral Maxillofac Pathol       Date:  2022-06-28

4.  Transforming growth factor-β1 and TGF-β2 act synergistically in the fibrotic pathway in oral submucous fibrosis: An immunohistochemical observation.

Authors:  Venkatesh Viswanath Kamath; Shruti Krishnamurthy; Krishnanand P Satelur; Komali Rajkumar
Journal:  Indian J Med Paediatr Oncol       Date:  2015 Apr-Jun

Review 5.  Genetic Susceptibility and Protein Expression of Extracellular Matrix Turnover-Related Genes in Oral Submucous Fibrosis.

Authors:  Ru-Hsiu Cheng; Yi-Ping Wang; Julia Yu-Fong Chang; Yu-Hwa Pan; Mei-Chi Chang; Jiiang-Huei Jeng
Journal:  Int J Mol Sci       Date:  2020-10-30       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.